|
1. Ebert, L.M., Liu, Y.C., Clements, C.S., Robson, N.C., Jackson, H.M., Markby, J.L., Dimopoulos, N., Tan, B.S., Luescher, I.F., Davis, I.D., Rossjohn, J., Cebon, J., Purcell, A.W., and Chen, W., A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine design. Cancer Res, 69(3): p. 1046-54 2009.
2. Ebert, L.M., Tan, B.S., Browning, J., Svobodova, S., Russell, S.E., Kirkpatrick, N., Gedye, C., Moss, D., Ng, S.P., Macgregor, D., Davis, I.D., Cebon, J., and Chen, W., The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells. Cancer Res, 68(8): p. 3001-9 2008.
3. Lev, A., Takeda, K., Zanker, D., Maynard, J.C., Dimberu, P., Waffarn, E., Gibbs, J., Netzer, N., Princiotta, M.F., Neckers, L., Picard, D., Nicchitta, C.V., Chen, W., Reiter, Y., Bennink, J.R., and Yewdell, J.W., The exception that reinforces the rule: crosspriming by cytosolic peptides that escape degradation. Immunity, 28(6): p. 787-98 2008.
4. Chen, W. and Mccluskey, J., Immunodominance and immunodomination: critical factors in developing effective CD8+ T-cell-based cancer vaccines. Adv Cancer Res, 95: p. 203-47 2006.
5. Jackson, H., Dimopoulos, N., Mifsud, N.A., Tai, T.Y., Chen, Q., Svobodova, S., Browning, J., Luescher, I., Stockert, L., Old, L.J., Davis, I.D., Cebon, J., and Chen, W., Striking immunodominance hierarchy of naturally occurring CD8+ and CD4+ T cell responses to tumor antigen NY-ESO-1. J Immunol, 176(10): p. 5908-17 2006.
6. Pang, K.C., Sanders, M.T., Monaco, J.J., Doherty, P.C., Turner, S.J., and Chen, W., Immunoproteasome subunit deficiencies impact differentially on two immunodominant influenza virus-specific CD8+ T cell responses. J Immunol, 177(11): p. 7680-8 2006.
Click Here For More
|